Who
Patrick K. Lucy
Director
Company insider
Files Form 4 as: Director, Dyadic International; Chief Business Officer, Pfenex.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $648K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 29 Jul 2014
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code M | —21,552 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —21,552 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —67,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —21,552 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —67,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —39,894 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —39,894 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code M | —21,552 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —23,585 at $0.00 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —67,500 at $0.00 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —21,552 at $0.00 | filing |
| 2 Jan 2025filed 7 Jan 2025 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code M | —23,585 | filing |
| 11 Apr 2024filed 15 Apr 2024 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —13,125 at $0.00 | filing |
| 3 Jan 2024filed 4 Jan 2024 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code M | —27,174 at $0.00 | filing |
| 3 Jan 2024filed 4 Jan 2024 | DYAI Dyadic InternationalBiotechnology | SEC FORM 4 Code M | —27,174 | filing |
| 2 Jan 2024filed 4 Jan 2024 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —23,585 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —27,174 at $0.00 | filing |
| 10 Jun 2022filed 14 Jun 2022 | DYAI Dyadic Internationaloption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.